Advisors
Scientific Advisors
Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London. He holds a PhD in Cancer Biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Our Principle Investigator for our planned PoC trial.
Professor James Spicer
Principal, Guys/KCL Partner
Holger Karsunky is the Co-Founder in Residence of Deep Valley Labs. He previously worked at Stemcentrx as Director of Cancer Biology. He attended the University of Duisburg-Essen in 1995.
Dr Holger Karsunky
Board Scientific Advisor
Clinical Immunopathologist, Professor of Cell and Tissue Therapy at UCL. Leading pioneer in cell therapies, including co-founding INmune Bio, Achilles Therapeutics, Cell Medica
Professor Mark Lowdell
Board Scientific Advisor
Manufacturing Advisors
Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London. He holds a PhD in Cancer Biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Our Principle Investigator for our planned PoC trial.
Professor James Spicer
Principal, Guys/KCL Partner
Holger Karsunky is the Co-Founder in Residence of Deep Valley Labs. He previously worked at Stemcentrx as Director of Cancer Biology. He attended the University of Duisburg-Essen in 1995.
Dr Holger Karsunky
Board Scientific Advisor
Clinical Immunopathologist, Professor of Cell and Tissue Therapy at UCL. Leading pioneer in cell therapies, including co-founding INmune Bio, Achilles Therapeutics, Cell Medica
Professor Mark Lowdell
Board Scientific Advisor
